Dean Sawyer has joined Palo Alto Health Sciences as its president and CEO. He comes to the Kirkland, WA-based company from Rx-Precision, where he was CEO. Sawyer’s experience also includes positions at Sentrian and Frost Data Capital. Palo Alto Health markets Freespira, a digital therapeutic that has FDA clearance for treating symptoms of panic disorder, panic attacks, and post-traumatic stress disorder.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
